SCHEMBL8395791

SCHEMBL8395791

N[C@H](B(O)O)C1CCCC1

nearest known ligand 0.42

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ EPHX1 P07099 3/20 0.37
▸ TP53 P04637 1/20 0.37
▸ KDM4E B2RXH2 1/20 0.36
▸ GMNN O75496 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ BLM P54132 1/20 0.36
▸ PMP22 Q01453 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ DPP4 P27487 8/20 0.35
▸ FAP Q12884 1/20 0.35
▸ DPP8 Q6V1X1 1/20 0.35
▸ DPP9 Q86TI2 1/20 0.35
▸ DPP7 Q9UHL4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9219185 0.97 KDM4E (0.39) EPHX1TP53KDM4EGMNNLMNA
SCHEMBL595080 0.67 — —
SCHEMBL14434506 0.67 — —
SCHEMBL9228117 0.67 TSHR (0.33) EPHX1TP53KDM4EGMNNLMNA
SCHEMBL1089229 0.65 EPHX1 (0.43) EPHX1TP53KDM4EGMNNLMNA
SCHEMBL3668939 0.65 — —
SCHEMBL1170371 0.65 TP53 (0.52) EPHX1TP53KDM4EGMNNLMNA
SCHEMBL1079175 0.65 — —
SCHEMBL22227354 0.65 TP53 (0.52) EPHX1TP53KDM4EGMNNLMNA
SCHEMBL10012157 0.65 TP53 (0.52) EPHX1TP53KDM4EGMNNLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0615978-B1 Peptide derivatives of the boronic acid having protease inhibiting activity, process for their production and pharmaceutical compositions comprising them ADIR (FR) 1999-05-12 — — EP disclosed
US-5444049-A Antithrombotic agents ADIR ET COMPAGNIE (FR) 1995-08-22 — — US disclosed
EP-0615978-A1 Peptide derivatives of the boronic acid having protease inhibiting activity, process for their production and pharmaceutical compositions comprising them ADIR ET COMPAGNIE (FR) 1994-09-21 — — EP disclosed
Send feedback